CSI Market
Sign In | Register

Processa Pharmaceuticals Inc (PCSA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PCSA Annual Balance Sheets →
From Processa Pharmaceuticals Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.20
Cash & Short-term Investments0.00
Other Current Assets0.47
Prepaid Expense And Other Assets Current1.40
Total Current Assets2.07
Equipment/Property/Plant Net0.00
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets2.07
Liabilities
Accounts Payable, Current AC1.66
Accrued Liabilities, Current AC0.73
Other Liabilities, Current0.00
Total Current Liabilities2.39
Total Long-term Debt0.00
Operating And Finance Lease Liability Current-
Total Liabilities2.39
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value0.00
Additional Paid In Capital Common Stock107.11
Retained Earnings / Accumulated Deficit-107.43
Other Equity0.00
Common Stockholder's Equity-0.32
Total Stockholder's Equity-0.32
Liabilities & Stockholder's Equity2.07
4 historic quarters locked

Sign in to unlock the full Processa Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Processa Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038334

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.